💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for ArQule, Inc. (ARQL)
« Back to company indexARQL Chatter Timeline
Stock Ticker for ARQL
Most Active Tweeters for ARQL
| User | Tweets |
|---|---|
| @jfais20 | 2 |
| @gcbioinv | 1 |
| @voxexnihilo | 1 |
| @cdespinoza1 | 1 |
Recent Tweets for ARQL
 |
@cdespinoza1 @iamjohn_c Nice! Just remember the $ARQL deal was announced as the results of Phase 1 for ARQ531 were released. Als… https://t.co/Q4Q11ubLMh July 11th 2020, 6:07pm |
 |
@voxexnihilo RT @jfais20: $APTO new presentation slides up (thanks WellsG)- important to note like $ARQL, CG-806 trial allows for intrapatient dose esca… July 10th 2020, 2:07pm |
 |
@jfais20 $APTO new presentation slides up (thanks WellsG)- important to note like $ARQL, CG-806 trial allows for intrapatien… https://t.co/kyfesodao4 July 10th 2020, 11:07am |
 |
@gcbioinv An interesting story told by former $ARQL CFO Marc Schegerin, formerly program director at $BIIB for Aducanumab Th… https://t.co/IYObQXmtxB July 8th 2020, 7:07am |
|
@jfais20 @SettleWilliam we might have to wait until ASH, but there is a chance they pull an $ARQL and disclose initial respo… https://t.co/CounhEnFDr July 7th 2020, 7:07pm |
 |
@ThirdEyeTobias @QuailTrading @Matthew_Hibbing $ARQL was around $10 right before it was acquired. https://t.co/zeCWgdkQ6o June 28th 2020, 3:06pm |
 |
@QuailTrading @Matthew_Hibbing Any idea what $ARQL price was prior to the buyout? https://t.co/bvV0UPWmss June 28th 2020, 2:06pm |
 |
@GantosJ @JacobPlieth @mergerfollower At EHA $APTO has only full dose Level-3 Let me remind you, $ARQL saw complete inhibit… https://t.co/ixziXKm4S6 June 23rd 2020, 10:06am |
 |
@grpetersen1 RT @ej23ny: $atnm to be honest I never considered HC Wainwright price target but think about it $arql was acquired for 2.8B based on phas… June 17th 2020, 9:06pm |
 |
@ej23ny $atnm to be honest I never considered HC Wainwright price target but think about it $arql was acquired for 2.8B b… https://t.co/6TFN9We2n5 June 17th 2020, 11:06am |
|
@gcbioinv @adamfeuerstein Aren't back from the dead stories the most interesting? $ARQL $BLU come to mind June 16th 2020, 8:06am |
 |
@Gambiste1 RT @GantosJ: @FinanceBubble $ARQL's ARQ 531 in B-cell malignancies, was in phase-1 the same as $APTO June 15th 2020, 9:06pm |
|
@GantosJ @FinanceBubble $ARQL's ARQ 531 in B-cell malignancies, was in phase-1 the same as $APTO June 15th 2020, 8:06pm |
 |
@GypsyDRB RT @GantosJ: The market is looking already for PR-Partial Response in $APTO's trial! But they forgot how long it took $ARQL & other BTK stu… June 12th 2020, 11:06am |
|
@GantosJ The market is looking already for PR-Partial Response in $APTO's trial! But they forgot how long it took $ARQL & ot… https://t.co/RtlygSnYGB June 12th 2020, 11:06am |
|
@GantosJ $ARQL's ARQ-531 start showing responses after a few scans of the recommended dose and I think CG-806 will follow th… https://t.co/b8UlML6n9O June 12th 2020, 11:06am |
 |
@DeschainGs RT @mtheory11bio: I’d love to see $APTO present ~ 1.4 to 1.6 micromolar of CG-806 in the 600mg patients at EHA later this week. $ARQL was… June 11th 2020, 6:06pm |
|
@jrock452 @NickBiotech @GantosJ Just need to have patience if you want to see $arql part 2 . June 3rd 2020, 12:06pm |
 |
@cpowerfitness RT @TradingTrooper: $SONO just hit a fresh HOD, +19%. Stock and option action giving me flashbacks to $ARQL.. (which bricked) May 21st 2020, 2:05pm |
 |
@TradingTrooper $SONO just hit a fresh HOD, +19%. Stock and option action giving me flashbacks to $ARQL.. (which bricked) https://t.co/x0CJth4PKq May 21st 2020, 2:05pm |
 |
@Kevvy_Kaye @Pharmdca @semodough For a double? How bout when I was pding the table on $ARQL at $3. May 20th 2020, 4:05pm |
 |
@TradeTexasBig RT @gcbioinv: Sighted at the grocery store $ARQL https://t.co/OdBI1MqYh4 May 16th 2020, 2:05pm |
|
@gcbioinv Sighted at the grocery store $ARQL https://t.co/OdBI1MqYh4 May 16th 2020, 1:05pm |
 |
@XBIObserver @GantosJ @cashbiotech Well, if the MYC candidate adds value, I'd like to see it fetch more than $ARQL. Heck look w… https://t.co/WXpJPWsmZY May 13th 2020, 3:05pm |
 |
@cashbiotech @GantosJ @XBIObserver Wow! And correct me if I’m wrong... at the time of BO $arql candidate ARQ 531 was being evalu… https://t.co/pXOlrNOwcG May 13th 2020, 3:05pm |
 |
@GantosJ @cashbiotech @XBIObserver I will make it easier for you, just check out how much $MRK paid for $ARQL 6 months ago,… https://t.co/vcvvNrLTte May 13th 2020, 3:05pm |
|
@jrock452 $APTO-- $arql part 2 in the works May 11th 2020, 10:05am |
 |
@lblegend33 @Biohazard3737 $Apto could be $arql part 2 bud May 7th 2020, 8:05pm |
 |
@Biohazard3737 Unfortunately, I didn’t stick with $ARQL, because it had „gone up too much“ and instead doubled down on $SNSS, thi… https://t.co/GPQMgQmtu1 May 7th 2020, 8:05pm |
 |
@monroewarriors5 @haodongvli Buyout on the same day as data release would be perfect just like $ARQL April 24th 2020, 11:04am |
|
@gcbioinv @Biohazard3737 Like the same kind of target engagement claim made by $SNSS $ARQL etc that actually was off in human… https://t.co/DS3FbYoPJM April 23rd 2020, 11:04am |
|
@gcbioinv $MRK has assigned new MK- designations to $ARQL drugs ARQ-531 -> MK-1026 ARQ-092 -> MK-7075 Haven't seen a new name for ARQ-751 yet April 20th 2020, 10:04am |
 |
@scottsherman @patrick03704225 Look up the $ARQL history. April 16th 2020, 3:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
